Stock News

Pfizer buys stake in French gene company in deal worth up to $636M
Invest in America’s Rising Healthcare Costs With These Stocks
Pfizer buys stake in French gene therapy firm Vivet
Pfizer Acquires Gene Therapy Portfolio in Deal that Could Total $636 Million
Pfizer Adds to Big Pharma's Gene-Therapy Deal Streak
Pfizer acquires option to buy Vivet Therapeutics for equivalent of $635.8 million
Pfizer Secures Exclusive Option to Acquire Gene Therapy Company Vivet Therapeutics
5 High-Quality, High-Yielding Stocks

As seen on...